Gemmer Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-79
| Closed | -$9K | – | 1487 |
|
|
2019
Q4 | $9K | Sell |
79
-2
| -2% | -$214 | ﹤0.01% | 714 |
|
|
2019
Q3 | $8K | Buy |
81
+4
| +5% | +$451 | ﹤0.01% | 783 |
|
|
2019
Q2 | $10K | Sell |
77
-10
| -11% | -$1.29K | ﹤0.01% | 680 |
|
|
2019
Q1 | $12K | Hold |
87
| – | – | ﹤0.01% | 624 |
|
|
2018
Q4 | $8K | Hold |
87
| – | – | ﹤0.01% | 736 |
|
|
2018
Q3 | $12K | Sell |
87
-2
| -2% | -$251 | ﹤0.01% | 630 |
|
|
2018
Q2 | $11K | Hold |
89
| – | – | ﹤0.01% | 677 |
|
|
2018
Q1 | $10K | Sell |
89
-5
| -5% | -$598 | ﹤0.01% | 709 |
|
|
2017
Q4 | $11K | Sell |
94
-44
| -32% | -$5.36K | ﹤0.01% | 681 |
|
|
2017
Q3 | $19K | Sell |
138
-9
| -6% | -$1.22K | 0.01% | 406 |
|
|
2017
Q2 | $18K | Buy |
147
+16
| +12% | +$1.86K | 0.01% | 414 |
|
|
2017
Q1 | $16K | Hold |
131
| – | – | 0.01% | 448 |
|
|
2016
Q4 | $16K | Buy |
131
+24
| +22% | +$2.94K | 0.01% | 427 |
|
|
2016
Q3 | $13K | Buy |
107
+9
| +9% | +$1.16K | 0.01% | 497 |
|
|
2016
Q2 | $11K | Hold |
98
| – | – | 0.01% | 532 |
|
|
2016
Q1 | $13K | Hold |
98
| – | – | 0.01% | 462 |
|
|
2015
Q4 | $19K | Hold |
98
| – | – | 0.01% | 319 |
|
|
2015
Q3 | $15K | Hold |
98
| – | – | 0.01% | 413 |
|
|
2015
Q2 | $18K | Hold |
98
| – | – | 0.01% | 355 |
|
|
2015
Q1 | $17K | Hold |
98
| – | – | 0.01% | 397 |
|
|
2014
Q4 | $18K | Hold |
98
| – | – | 0.01% | 354 |
|
|
2014
Q3 | $16K | Hold |
98
| – | – | 0.01% | 387 |
|
|
2014
Q2 | $15K | Hold |
98
| – | – | 0.01% | 422 |
|
|
2014
Q1 | $14K | Buy |
+98
| New | +$15.6K | 0.01% | 441 |
|
Other funds holding ALXN
BBA
